{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:04:48Z","timestamp":1774620288388,"version":"3.50.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People&apos;s Republic of China","doi-asserted-by":"publisher","award":["NSC 102-2113-M-009-010"],"award-info":[{"award-number":["NSC 102-2113-M-009-010"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.jconrel.2015.12.036","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T01:45:29Z","timestamp":1450921529000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"special_numbering":"C","title":["Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo observation"],"prefix":"10.1016","volume":"224","author":[{"given":"Hao-Syun","family":"Chou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6755-8418","authenticated-orcid":false,"given":"Mikael","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Hsuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"R\u00f6ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus","family":"Nyd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean-Mo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2015.12.036_bb0005","series-title":"IDF Diabetes Atlas","year":"2013"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0010","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0015","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0020","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3122\/jabfm.18.3.199","article-title":"Basal insulin therapy in type 2 diabetes","volume":"18","author":"Bethel","year":"2005","journal-title":"J. Am. Board Fam. Pract."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0035","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(02)00024-X","article-title":"Modulated insulin permeation across a glucose-sensitive polymeric composite membrane","volume":"80","author":"Zhang","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0040","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.biomaterials.2011.10.072","article-title":"A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles","volume":"33","author":"Peng","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","article-title":"Inhaled insulin\u2014intrapulmonary, intranasal, and other routes of administration: mechanisms of action","volume":"26","author":"Henkin","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v4.i1.1","article-title":"Insulin therapies: current and future trends at dawn","volume":"4","author":"Yaturu","year":"2013","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0060","first-page":"B109","article-title":"Long-acting insulin analogs","volume":"22","author":"Rosskamp","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0065","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/diabetes.53.6.1614","article-title":"Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes","volume":"53","author":"Heise","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0070","first-page":"A4","article-title":"New insulin preparations with prolonged action profiles-A21-modified arginine insulin","volume":"35","author":"Seipke","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0075","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1021\/nn400630x","article-title":"Injectable nano-network for glucose-mediated insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0080","doi-asserted-by":"crossref","DOI":"10.5772\/56768","article-title":"Evaluation of carboxymethyl-hexanoyl chitosan as a protein nanocarrier","volume":"3","author":"Larsson","year":"2013","journal-title":"Nanomater. Nanotechnol."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0085","doi-asserted-by":"crossref","first-page":"11800","DOI":"10.1021\/jp902103p","article-title":"Self-assembly behavior and doxorubicin-loading capacity of acylated carboxymethyl chitosans","volume":"113","author":"Liu","year":"2009","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0090","doi-asserted-by":"crossref","first-page":"6580","DOI":"10.1039\/C4TB01080A","article-title":"A pH-responsive amphiphilic chitosan-pyranine core-shell nanoparticle for controlled drug delivery, imaging and intracellular pH measurement","volume":"2","author":"Chou","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0095","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jconrel.2012.05.038","article-title":"Design and characterization of a novel amphiphilic chitosan nanocapsule-based thermo-gelling biogel with sustained in vivo release of the hydrophilic anti-epilepsy drug ethosuximide","volume":"161","author":"Hsiao","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0100","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1016\/j.actbio.2014.03.016","article-title":"A temperature-induced and shear-reversible assembly of latanoprost-loaded amphiphilic chitosan colloids: characterization and in vivo glaucoma treatment","volume":"10","author":"Hsiao","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P","article-title":"Use of chitosan as a biomaterial: studies on its safety and hemostatic potential","volume":"34","author":"Rao","year":"1997","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0110","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.foodchem.2009.02.002","article-title":"Low molecular weight chitosan prepared with the aid of cellulase, lysozyme and chitinase: characterisation and antibacterial activity","volume":"116","author":"Lin","year":"2009","journal-title":"Food Chem."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0115","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1016\/j.carres.2005.07.022","article-title":"The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation","volume":"340","author":"Ren","year":"2005","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0120","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0142-9612(00)00326-4","article-title":"In vitro degradation of chitosan by a commercial enzyme preparation: effect of molecular weight and degree of deacetylation","volume":"22","author":"Zhang","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0009-8981(74)90398-2","article-title":"Lysozyme in human body fluids","volume":"57","author":"Hankiewicz","year":"1974","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/35090602","article-title":"Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate","volume":"412","author":"Vocadlo","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0135","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/abbi.1996.9828","article-title":"Purification, characterization, and biosynthesis of bovine cartilage lysozyme isoforms","volume":"339","author":"Moss","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0140","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1016\/S0142-9612(02)00011-X","article-title":"In vitro degradation of chitosan by bacterial enzymes from rat cecal and colonic contents","volume":"23","author":"Zhang","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0145","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1389203003381315","article-title":"The use of circular dichroism in the investigation of protein structure and function","volume":"1","author":"Kelly","year":"2000","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.jconrel.2015.12.036_bb0150","doi-asserted-by":"crossref","first-page":"6511","DOI":"10.1021\/ma8002399","article-title":"Self-assembled hollow nanocapsule from amphiphatic carboxymethyl-hexanoyl chitosan as drug carrier","volume":"41","author":"Liu","year":"2008","journal-title":"Macromolecules"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1399-3089.2009.00548.x","article-title":"Diabetic rats and mice are resistant to porcine and human insulin: flawed experimental models for testing islet xenografts","volume":"16","author":"Pepper","year":"2009","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0160","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1073\/pnas.85.7.2403","article-title":"Enzymatically controlled drug delivery","volume":"85","author":"Fischel-Ghodsian","year":"1988","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0165","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.1073\/pnas.1005704107","article-title":"Supramolecular insulin assembly II for a sustained treatment of type 1 diabetes mellitus","volume":"107","author":"Gupta","year":"2010","journal-title":"PNAS"},{"key":"10.1016\/j.jconrel.2015.12.036_bb0170","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1155\/2012\/984780","article-title":"Caffeic acid phenylethyl amide protects against the metabolic consequences in diabetes mellitus induced by diet and streptozocin","volume":"2012","author":"Weng","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591530287X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836591530287X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:30:43Z","timestamp":1759159843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836591530287X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":34,"alternative-id":["S016836591530287X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.036","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Injectable insulin-lysozyme-loaded nanogels with enzymatically-controlled degradation and release for basal insulin treatment: In vitro characterization and in vivo observation","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2015.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}